New medicines in our portfolio

  1. Tibsovo (ivosidenib)
    Tibsovo (ivosidenib)
    by Agios Pharmaceuticals, Inc.
    for Leukemia
    €33,468.00
  2. Piqray (alpelisib)
    Piqray (alpelisib)
    by Novartis
    for Breast Cancer
    €22,537.00
  3. Palynziq (pegvaliase-pqpz)
    Palynziq (pegvaliase-pqpz)
    by BioMarin Pharmaceutical Inc.
    for phenylketonuria (PKU)
    €636.20
  4. Cuprior (trientine)
    Cuprior (trientine)
    by GMP-Orphan (GMPO)
    for Wilson's disease
    €6,724.30
  5. Tecfidera (dimethyl fumarate)
    Tecfidera (dimethyl fumarate)
    by Biogen
    for Multiple Sclerosis
    €1,148.50
  6. Mayzent (siponimod)
    Mayzent (siponimod)
    by Novartis
    for Multiple Sclerosis
    €20,985.00
  7. Tudcabil (tauroursodeoxycholic acid)
    Tudcabil (tauroursodeoxycholic acid)
    by Bruschettini s.r.l.
    for Amyotrophic Lateral Sclerosis (ALS)
    €22.38
  8. Libtayo (cemiplimab-rwlc)
    Libtayo (cemiplimab-rwlc)
    by Sanofi
    for Skin Cancer
    €3,147.60
View as Grid List

8 Items

per page
Set Descending Direction